- Home
- ADPT vs SCS Comparison
ADPT vs SCS Comparison
Compare ADPT & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- SCS
- Stock Information
- Founded
- ADPT 2009
- SCS 1912
- Country
- ADPT United States
- SCS United States
- Employees
- ADPT N/A
- SCS N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- SCS Office Equipment/Supplies/Services
- Sector
- ADPT Health Care
- SCS Consumer Discretionary
- Exchange
- ADPT Nasdaq
- SCS Nasdaq
- Market Cap
- ADPT 1.8B
- SCS 1.8B
- IPO Year
- ADPT 2019
- SCS 1998
- Fundamental
- Price
- ADPT $12.92
- SCS $16.23
- Analyst Decision
- ADPT Strong Buy
- SCS Buy
- Analyst Count
- ADPT 8
- SCS 1
- Target Price
- ADPT $12.38
- SCS $16.00
- AVG Volume (30 Days)
- ADPT 2.1M
- SCS 3.0M
- Earning Date
- ADPT 08-05-2025
- SCS 09-17-2025
- Dividend Yield
- ADPT N/A
- SCS 2.47%
- EPS Growth
- ADPT N/A
- SCS 37.12
- EPS
- ADPT N/A
- SCS 1.04
- Revenue
- ADPT $205,216,000.00
- SCS $3,217,700,000.00
- Revenue This Year
- ADPT $24.39
- SCS $4.30
- Revenue Next Year
- ADPT $20.44
- SCS $3.51
- P/E Ratio
- ADPT N/A
- SCS $15.56
- Revenue Growth
- ADPT 21.60
- SCS 2.64
- 52 Week Low
- ADPT $3.98
- SCS $9.32
- 52 Week High
- ADPT $13.37
- SCS $17.13
- Technical
- Relative Strength Index (RSI)
- ADPT 69.79
- SCS 77.49
- Support Level
- ADPT $10.66
- SCS $15.80
- Resistance Level
- ADPT $13.37
- SCS $16.63
- Average True Range (ATR)
- ADPT 0.81
- SCS 0.49
- MACD
- ADPT 0.23
- SCS 0.38
- Stochastic Oscillator
- ADPT 86.82
- SCS 87.18
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.